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The in vitro antiplasmodial activity of Ambrosia tenuifolia organic extract and its isolated sesquiterpene lactones, psilostachyin
and peruvin, has been evaluated against Plasmodium falciparum F32 and W2 strains. The cytotoxicity of both compounds was
determined on lymphoid cells, and their corresponding selectivity indexes (SIs) were calculated. Peruvin was the most active
compound on F32 strain of P. falciparum with a 50% inhibitory concentration value (IC50)o f0 . 3 μg/mL (1.1μM) whereas
psilostachyin showed activity on both strains (IC50 = 0.6 (2.1μM) and 1.8μg/mL (6.4μM)). Fifty percent cytotoxic concentration
(CC50) values (48h) were 6.8μg/mL (24.3μM) and 10.0μg/mL (37.9μM) for psilostachyin and peruvin, respectively.
1.Introduction
Malaria is a major parasitic infection in tropical and sub-
tropical regions of the world, particularly devastating in sub-
Saharan Africa where 90% of the cases and deaths occur [1].
According to the World Health Organization (WHO), over
a million people die from malaria every year, and roughly
a 40% of the population is at risk of becoming infected. In
America, this infection spreads from Northern to Southern
America, being Brazil and the Andes Region, the areas where
the greatest number of cases is recorded [2].
Medicinal plants have provided valuable antimalar-
ial drugs such as quinine and artemisinin. The discov-
ery of these drugs, which are currently being used, has
prompted the evaluation of other medicinal plants in
the search of new antimalarial agents that are not only
active against drug-sensitive but also against drug-resistant
and multidrug-resistant strains of Plasmodium falciparum.
Although artemisinin, a sesquiterpene lactone (STL), is the
most powerful drug against chloroquine-resistant malaria,
resistance to this drug might soon appear. Therefore, there
is an urgent need for new therapeutic agents [3].
In previous studies we have demonstrated that the
CH2Cl2 :MeOH (1:1) of Ambrosia tenuifolia has a signif-
icant trypanocidal activity against Trypanosoma cruzi epi-
mastigotes [4]. Besides, its essential oil showed antiplasmo-
dial activity against chloroquine-sensitive and chloroquine-
resistant strains of P. falciparum [5]. A. tenuifolia Sprengel
(Asteraceae) is an Argentine medicinal species known as
“ajenjo del campo,” “altamisa,” or “artemisia” which is
traditionally used for the treatment of intermittent fevers
[6, 7].
A bioguided assay fractionation of the CH2Cl2 :MeOH
(1:1) extract of A. tenuifolia led to the isolation of two
STLs, belonging to the pseudoguaianolide type, identiﬁed as
psilostachyin and peruvin (Figure 1). Both compounds were
active against T. cruzi and showed antileishmanial activity
against Leishmania mexicana promastigotes [8]. The eﬀectof
psilostachyin onthegrowthofT. cruzi epimastigotes withthe
addition of glutathione and at the ultrastructural level of the
parasite has been reported [9].
These ﬁndings prompted us to assess the activity of
A. tenuifolia organic extract and its isolated compounds,
psilostachyin and peruvin, on both chloroquine-sensitive2 Evidence-Based Complementary and Alternative Medicine
O O
O
O
O
O
O
OH
OH
Peruvin Psilostachyin
Figure 1: Chemical structure of sesquiterpene lactones isolated
from Ambrosia tenuifolia.
(F32) and chloroquine-resistant strains (W2) of P. falci-
parum. Cytoxicity of such compounds on lymphoid cells has
been also tested.
2.Materialsand Methods
2.1. Plant Material. The aerial parts of A. tenuifolia were
collectedinPunta Lara, Province ofBuenosAires, Argentina,
in April 2007. The plant material was identiﬁed by Dr. G.
Giberti, and a voucher specimen (BAF 660) is deposited at
the Herbarium of the Museo de Farmacobot´ anica, Facultad
de Farmacia y Bioqu´ ımica, Universidad de Buenos Aires.
2.2. Extraction of Plant Material. Dried aerial parts (1000g)
of A. tenuifolia were extracted with CH2Cl2 :MeOH (1:1)
(10L)atroomtemperaturefor24handvacuumﬁltered.The
process was repeated twice, and the ﬁltrates were combined
and dried under vacuum.
2.3. Isolation of Psilostachyin and Peruvin. Psilostachyin and
peruvinwereisolatedfromtheorganicextractofA.tenuifolia
as previously described [8]. The purity of psilostachyin
and peruvin was conﬁrmed by High Performance Liquid
Chromatography (HPLC):HPLC-DAD (Waters), gradient
H2O:MeOH 0–70% for 20min, 70–100% for 10min; C18
column (LiChrospher 5 microns, 125 × 4mm, Merck) ﬂow
1.0mL/min.
2.4. Parasite Strains and Culture Media. Plasmodium falci-
parum F32-Tanzania strain (chloroquine sensitive, kindly
provided by Dr. Fandeur T, Pasteur Institute, Kayenne) and
P. falciparum W2 strain (chloroquine resistant, kindly pro-
vided by Dr Eduardo Ortega Barria, INDICASAT Institute,
Panam´ a) were cultured in RPMI 1640 medium supple-
mented with 10% human serum and a hematocrit of 4%
(Blood group O, RH+) at 37◦Ci na na n a e r o b i ca t m o s p h e r e
[10].
2.5. Animals. Inbred female BALB/c mice (22 ± 2g) were
purchased from the Instituto Nacional de Tecnolog´ ıa
Agropecuaria (INTA). Animals were kept according to the
Guide for the Care and Use of Laboratory Animals, US
National Research Council [11].
2.6. In Vitro Antiplasmodial Activity Assay. Parasite growth
was synchronized at 1% parasitemia and 2% hematocrite
and distributed in a volume of 100μLi np l a t e so f9 6
wells by duplicate. Antiplasmodial activity was evaluated
in concentrations between 100 and 0.01μg/mL for both
the organic extract and isolated compounds. 100μLo f
each dilution (in DMSO, at no more than 0.1% ﬁnal
concentration) was added to each well. Parasites were then
incubated at 37◦C for 48h. After incubation, smears were
prepared, ﬁxed with methanol, and stained with Giemsa.
The antiplasmodial activity was determined by microscopy
counting of noninfected red cells and infected red cells.
The 50% inhibitory concentrations (IC50)o ft h ee x t r a c ta n d
the compounds were calculated graphically using CRICKET
GRAPH 1.3 software. Chloroquine (10–1000nM) (Sigma-
A l d r i c h )w a su s e da sap o s i t i v ec o n t r o l ,a n dD M S Ow a s
employed as negative control. All assays were carried out in
triplicate.
2.7. Cytotoxicity Assay. Lymphoid cell suspensions were
obtained from the lymph nodes of BALB/c mice as pre-
viously reported [8]. Brieﬂy, T-cell enriched populations
were obtained by passage of the cell suspension through
a nylon wool column. T-cell presence was higher than
97% as checked by indirect immunoﬂuorescence after lysis
with anti-Thy plus complement. Cells were cultured at a
concentration of 2 × 106 cells/mL in RPMI 1640 medium
(GIBCO) supplemented with 10% fetal calf serum, 2mM
glutamine, 100U/mL penicillin, and 100μg/mL strepto-
mycin. Cells were adjusted to a ﬁnal volume of 0.2mL per
well in a 96-well microtiter plate and cultured at 37◦Ci n
a5 %C O 2 atmosphere for 3, 24, and 48h. Cell viability
was determined by the trypan blue exclusion method in the
absence and presence of increasing concentrations of the
compounds (0.1, 1, 10, and 50μg/mL) and was expressed
as % of basal values, calculated as [number of viable
cells/number of total cells] × 100. Then, data of viability
were transformed in cytotoxicity values (100-% of viability)
to calculate the 50% cytotoxic concentration (CC50)w h i c h
was ﬁnally calculated using CRICKET GRAPH 1.3 software.
The tests were performed in triplicate. The selectivity index
(SI) was used to compare the toxicity for mammalian cells
and the activity against the parasites and calculated as the
CC50 on murine T lymphocytes (48h) divided by the 50%
inhibitory concentration (IC50) of the compound for both
strains of P. falciparum.
3.Resultsand Discussion
The organic extract of Ambrosia tenuifolia was assayed in
vitro on P. falciparum F32 strain. This extract showed
promising antiplasmodial activity with a growth inhibition
of 77.1 ± 1.22% (10μg/mL), with an IC50 value of 2μg/mL
(Table 1). Psilostachyin and peruvin, two STLs isolated
from this extract, were tested for their ability to inhibit the
same P. falciparum strain and a chloroquine-resistant strain
(W2). These STLs were active on both parasite strains but
showed stronger activity on the F32 strain. Peruvin was theEvidence-Based Complementary and Alternative Medicine 3
Table 1: In vitro antiplasmodial activity, cytotoxicity and selectivity indexes of Ambrosia tenuifola extract, psilostachyin and peruvin.
Extract/Compounds
IC50 (μM) CC50 (μM) Selectivity Index
P. falciparum P. falciparum 48h P. falciparum P. falciparum
F32 strain W2 strain F32 strain W2 strain
CH2Cl2 :MeOH(1:1) 2.0 ±0.09∗ n.t. n.t. n.c. n.c.
Psilostachyin 2.1 ±0.15 6.4 ± 0.48 24.3 ±0.21 11.6 ±0.95 3.8 ±0.25
Peruvin 1.1 ±0.09 18.9 ± 0.95 37.9 ±0.34 34.4 ±2.40 2.0 ±0.15
Chloroquine 0.03 ±0.002 2.8 ± 0.19 n.t. n.c. n.c.
n . t . :n o tt e s t e d ;n . c . :n o tc a l c u l a t e d .
∗Expressed as μg/ML.
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Figure 2: Eﬀects of psilostachyin (a) and peruvin (b) on T-
lymphocyte viability. Cultures were done in 96-well plates with 2
× 106 lymphocytes/mL during 3, 24 or 48h in the presence of
diﬀerent concentrations (0.1 to 50μg/mL) of the compounds. Cell
viability was determined by the trypan blue exclusion method and
is expressed as viability. Bars represent the means ± SEM.
most active compound on this strain with an IC50 value of
0.3μg/mL(1.1μM)whereaspsilostachyin showed activityon
bothF32and W2strains withIC50 valuesof0.6(2.1μM) and
1.8μg/mL (6.4μM), respectively (Table 1).
The isolated compounds were evaluated for their cyto-
toxicity on T-cells at 3, 24 and 48h (Figure 2). The CC50
values (48h) for psilostachyin and peruvin and the SIs were
calculated and are shown in Table 1.
This is the ﬁrst report on the antiplasmodial activity
of psilostachyin and peruvin. The IC50 values for these
compounds were in the μM range as it has been reported for
otherSTLs[12]andparticularlyforpseudoguaianolidessuch
as helenalin and its ester derivatives [13].
Antiplasmodial activity of this kind of compounds has
been usually associated with high cytotoxicity [14, 15].
However, certain STLs, mainly from the pseudoguaianolide
type, are considerably more toxic to the parasites than to
mammalian cells [13]. These ﬁndings suggest that other
structural features are governing the antiplasmodial activity
of this kind of compounds besides the eﬀect related to the
α-methylene-γ-lactone group (Michael addition).
Since the discovery of artemisinin against chloroquine-
resistant malaria, attention has been paid to other STLs as
a potential source of antimalarial drugs. The results shown
herein for psilostachyin and peruvin, on P. falciparum,m a k e
these molecules interesting scaﬀolds to generate leads with
enhanced antiplasmodial activity and reduced cytotoxicity.
Further investigation will include the in vivo studies and the
molecular mechanism of action of these compounds.
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